Colchicine is a time-honored treatment for gout and familial Mediterranean fever, with its use dating back thousands of years. While colchicine has historically been associated with these conditions, recent research has expanded its therapeutic potential, highlighting its promise as an anti-inflammatory agent with applications in a variety of other medical fields. Understanding its mechanism of action and safety profile helps guide the expanding role of this medication in treatment and supports evidence-based decisions about its use.
[signup]
What Is Colchicine?
Colchicine is an anti-gout medication derived from the autumn crocus plant. Although its use for treating joint pain dates back to ancient Egypt, the U.S. Food and Drug Administration (FDA) did not approve it until 2009.
Colchicine is administered orally as a tablet, capsule, or solution.
Conditions Treated by Colchicine
The FDA has approved colchicine for:
- Preventing and treating acute gout (gouty arthritis) flares in adolescents and adults older than 16 years
- Treating familial Mediterranean fever (FMF) in children and adults older than 4 years
Most recently, in 2023, the FDA also approved low-dose colchicine as the first anti-inflammatory agent to reduce cardiovascular events, including heart attack, stroke, and cardiovascular-related death, in adults who have atherosclerotic cardiovascular disease (ASCVD) or are at risk of developing it.
Colchicine has also been used off-label to treat:
- Pericarditis
- Primary biliary cirrhosis
- Liver cirrhosis
- Dermatitis herpetiformis
- Paget's disease of bone
- Chronic immune thrombocytopenia
- Idiopathic thrombocytopenic purpura
- Pseudogout
- Idiopathic pulmonary fibrosis
These are not FDA-approved indications for colchicine. If colchicine is used to treat these conditions, it should be done cautiously and only under the supervision of a healthcare professional.
How Does Colchicine Work?
Despite its long history of use, scientists are still working to understand exactly how colchicine works. It is known to interfere with the inflammatory processes involved in causing symptoms of gout and FMF by targeting microtubules, making it unique compared to other anti-inflammatory drugs like non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids.
Microtubules are structures inside cells that help maintain cell shape and enable essential functions like cell division and movement. These microtubules are made of small building blocks called tubulin. Colchicine binds to tubulin, preventing the growth of microtubules and disrupting their normal function.
In doing so, colchicine impairs the function of certain white blood cells, such as neutrophils, macrophages, and mast cells, which play key roles in the body's inflammatory response. It stops these cells from migrating and releasing chemicals that promote inflammation. This action helps reduce the pain and swelling caused by inflammatory conditions like gout and FMF.
Dosage and Administration
Colchicine dosage may vary depending on the type of condition being treated, age, and coexisting medical conditions. General dosing guidelines are outlined below, but always take colchicine as your doctor prescribes.
Gout
- Prevention of Gout Flares: 0.6 mg one to two times daily
- Treatment of Gout Flares: 1.2 mg at the first sign of a flare, followed by 0.6 mg one hour later
Dose Adjustments:
- Severe Renal (Kidney) Impairment in Gout Prevention: Initate treatment at 0.3 mg daily. Any increase in dose should be done with close patient monitoring.
- Severe Renal Impairment in Gout Treatment: Do not repeat more than once every two weeks.
- The use of colchicine is not recommended for treating acute gout flares in patients with renal impairment already receiving colchicine for gout prevention.
- Dialysis: The recommended dose for gout prophylaxis is 0.3 mg twice weekly with close monitoring. To treat gout flares, reduce the dose to one dose of 0.6 mg, and do not repeat the treatment more than once every two weeks.
- Severe Hepatic (Liver) Impairment in Gout Prevention: A dose reduction may be needed.
- Severe Hepatic Impairment in Gout Treatment: Treatment should not be repeated more than once every two weeks.
Familial Mediterranean Fever
- Adults and Children Older than 12 Years: 1.2-2.4 mg daily, taken as a single dose or split between two divided doses
- Children 6 to 12 Years: 0.9-1.8 mg, taken as a single dose or split between two divided doses
- Children 4-6 Years: 0.3-1.8 mg, taken as a single dose or split between two divided doses
Dose Adjustments:
- Severe Renal Impairment and Dialysis: Initiate treatment at 0.3 mg daily. Any increase in dose should be done with close patient monitoring.
- Severe Hepatic Impairment: A dose reduction may be needed.
Cardiovascular Risk Reduction
- Adults: 0.5mg once daily
Benefits and Risks of Colchicine
Let's discuss the benefits of colchicine and the potential risks and side effects associated with its use.
Key Benefits
- Two randomized clinical trials demonstrated that colchicine 0.6 mg administered twice daily significantly decreased the frequency of gout flares in patients initiating urate-lowering therapy.
- The colchicine regimen for treating acute gout flares has been shown to be effective in reducing pain, with a significant proportion of patients achieving at least 50% pain reduction at 24 hours compared to placebo.
- Clinical studies have shown that colchicine significantly reduces the frequency of FMF attacks. In one small study, patients treated with colchicine experienced five attacks over 90 days compared to 59 attacks with placebo.
- In patients with coronary artery disease who are already receiving standard medical care, low-dose colchicine has been shown to safely reduce adverse cardiovascular events by 31% in those with stable atherosclerosis and by 23% following a recent heart attack.
Potential Risks and Side Effects
Gastrointestinal side effects are most commonly reported by people taking colchicine:
- Diarrhea
- Vomiting
- Nausea
- Abdominal cramping
Other less common side effects may include:
- Numbness and tingling
- Muscle pain and weakness
- Hair loss
- Rash
- Low white blood cell counts
- Elevated liver enzymes
- Reduced sperm counts
Most side effects are mild and reversible by lowering the dose or discontinuing the medication.
Safety Considerations and Warnings
Colchicine is not safe for everyone.
Who Should Avoid Colchicine?
- Patients with renal or hepatic impairment who are taking medications that inhibit P-glycoprotein or CYP3A4
- Patients with renal failure
- Patients with pre-existing blood dyscrasias (conditions that affect the blood, bone marrow, or lymph tissue)
Precautions
- Pregnancy: Colchicine is classified as a pregnancy category C drug. It is recommended during pregnancy only if the potential benefit to the mother justifies the possible risk to the fetus.
- Breastfeeding: While colchicine is excreted into human breast milk, the American Academy of Pediatrics considers it safe to take while breastfeeding based on evidence suggesting no increased risk of adverse effects on breastfed infants.
- Geriatrics: Older adults often have reduced kidney and liver function, which can increase the risk of drug toxicity. Dose adjustments may be necessary based on kidney and liver function, and close monitoring for side effects is important.
Drug Interactions and Overdose Risks
Colchicine can interact with certain medications, increasing the risk of side effects. The most significant interactions occur with drugs that inhibit P-glycoprotein or CYP3A4, as these can elevate colchicine's systemic levels, potentially leading to toxicity.
Examples of drug interactions to be aware of include:
- HIV Antivirals: atazanavir, fosamprenavir, ritonavir
- Antibiotics: erythromycin, clarithromycin
- Antifungals: fluconazole, itraconazole, ketoconazole
- Calcium Channel Blockers: diltiazem, verapamil
- Statins: atorvastatin, lovastatin, simvastatin
- Cyclosporine
- Grapefruit or grapefruit juice
This is not a complete list of possible drug interactions. Always give your doctor a list of all medications, herbs, and supplements you take before starting colchicine to prevent adverse side effects.
Colchicine Toxicity
Colchicine toxicity typically progresses in two stages:
- 24 Hours After Ingestion: abdominal pain, nausea, vomiting, diarrhea, dehydration, increased white blood cell count
- 24-72 Hours After Ingestion: multi-organ failure, respiratory depression, cardiovascular collapse, death
There is no specific antidote for colchicine poisoning. Treatment focuses on supportive care, which may include:
- Gastric lavage (to remove the drug from the stomach)
- Measures to prevent shock
- Symptomatic management aims to stabilize the patient while their body recovers from the effects of the drug
Common Questions About Colchicine
How long does colchicine take to work?
Colchicine is a fast-acting medication that can reduce pain and inflammation within three hours of the first dose.
Can colchicine be taken with other medications?
It depends on the medication. Always consult a healthcare provider before combining colchicine with other drugs.
What do I do if I miss a dose?
Take the missed dose as soon as you remember. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.
[signup]
Key Takeaways
- Colchicine is a well-established FDA-approved treatment for gout and FMF.
- Research highlights its expanding potential in treating other inflammatory conditions, prompting new FDA approval in 2023 for reducing cardiovascular risk in patients with atherosclerotic cardiovascular disease.
- Potential side effects of colchicine include gastrointestinal discomfort, muscle weakness, hair loss, and more serious risks like toxicity, especially if the drug interacts with other medications or is not properly dosed in patients with kidney or liver impairments.
- Anyone considering colchicine as a treatment should consult a doctor to ensure its efficacy and safety, especially when combining it with other medications.
%201.svg){kind=logo}
